<DOC>
	<DOC>NCT01309334</DOC>
	<brief_summary>Multicenter open-label prospective comparative study of PET-scan and MRI at the time of diagnosis, after 3 cycles of induction therapy (RVD) and at the completion of therapy.</brief_summary>
	<brief_title>Imaging Young Myeloma (IMAgerie JEune My√©lome)</brief_title>
	<detailed_description />
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms, Plasma Cell</mesh_term>
	<criteria>symptomatic de novo multiple myeloma less than 65 years of age enrolled in the IFM/DFCI clinical trial 66 years of age or more not eligible for highdose therapy Consindications to MRI or PETScan</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>MRI</keyword>
	<keyword>PET-scan</keyword>
	<keyword>multiple myeloma</keyword>
	<keyword>prognosis</keyword>
	<keyword>pharmacoeconomic analysis</keyword>
</DOC>